SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-22-031721
Filing Date
2022-12-12
Accepted
2022-12-12 16:02:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 kerostherapeuticsinc424b5-.htm 424B5 376660
2 EX-FILING FEES exhibit107-424b5.htm EX-FILING FEES 29086
3 image_0a.jpg GRAPHIC 30676
  Complete submission text file 0001628280-22-031721.txt   449100
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255724 | Film No.: 221457134
SIC: 2834 Pharmaceutical Preparations